Next Article in Journal
Proteomics Analysis Reveals an Important Role for the PPAR Signaling Pathway in DBDCT-Induced Hepatotoxicity Mechanisms
Previous Article in Journal
Isopentyl-Sulfide-Impregnated Nano-MnO2 for the Selective Sorption of Pd(II) from the Leaching Liquor of Ores
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 22
Issue 7
10.3390/molecules22071103
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis and Fungicidal Activity of 1-(Carbamoylmethyl)-2-aryl-3,1-benzoxazines

by
Zi-Long Tang
1,2,*,
Lian Wang
1,2,
Jing-Zhao Tan
1,2,
Yi-Chao Wan
1 and
Yin-Chun Jiao
2
1
Key Laboratory of Theoretical Organic Chemistry and Functional Molecule of Ministry of Education, Hunan University of Science and Technology, Xiangtan 411201, China
2
School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan 411201, China
*
Author to whom correspondence should be addressed.
Molecules 2017, 22(7), 1103; https://doi.org/10.3390/molecules22071103
Submission received: 8 June 2017 / Revised: 25 June 2017 / Accepted: 27 June 2017 / Published: 6 July 2017
(This article belongs to the Section Organic Chemistry)
Browse Figures
Versions Notes

Abstract

:
A series of new 1-(carbamoylmethyl)-2-aryl-3,1-benzoxazines were prepared in moderate to good yields by BF3·OEt2-catalyzed reactions of aromatic aldehydes with 2-(N-substituted carbamoylmethylamino)benzyl alcohols. The structures of the target compounds were confirmed by IR, 1H-NMR, 13C-NMR, and elemental analyses. The fungicidal activities of the target compounds against plant fungi were preliminarily evaluated, and some of them exhibited good activity.

Graphical Abstract

1. Introduction

3,1-Benzoxazine and 3,1-benzoxazinone derivatives have received growing attention due to their broad biological activities. 3,1-Benzoxazine derivatives show anticonvulsant [1], herbicidal [2], fungicidal [3,4], and anticancer activity [5], and some are potent progesterone receptor (PR) agonists [6] or DNA-binding antitumor agents [7]. 3,1-Benzoxazinones exhibit antihypertensive [8] and antiproliferative activities [9], or are potent PR agonists/antagonists [10,11], potent human leukocyte elastase inhibitors [12], serine protease inhibitors [13,14,15], long chain fatty acid elongase 6 inhibitors [16], NK1/NK3 receptor antagonists [17], α-chymotrypsin inhibitors [18], mineralocorticoid receptors antagonists [19], and are even used as anti-HIV-1 reverse transcriptase inhibitors [20,21]. Therefore, the synthesis of 3,1-benzoxazines and 3,1-benzoxazinone has attracted considerable interest. The condensation of 2-aminobenzyl alcohol or its derivatives with aldehydes using acetic acid or p-toluenesulfonic acid (TsOH) as catalyst is the widely-used way to synthesize 3,1-benzoxazines [6,22,23]. Palladium-catalyzed cyclization of 2-alkynylanilides also provides a route to substituted 3,1-benzoxazines [24]. Recently, hypervalent iodine-mediated oxygenation of tertiary amines afforded a new way [25]. As for 3,1-benzoxazinones, the frequently used protocol is the reaction of 2-aminobenzyl alcohol or its derivatives with phosgene [8,26]. More recently, silver-catalyzed incorporation of carbon dioxide into 2-alkynylanilides afforded a new route [27]. In spite of the progress in their preparation, the development of more efficient ways and the synthesis of novel 3,1-benzoxazine derivatives are still highly desirable for drug discovery, as well as medicinal and pesticide chemistry. To our knowledge, 3,1-benzoxazines have received less attention compared with 3,1-benzoxazinones. Particularly, there are only few reports about the activities of benzoxazines against plant fungi [3,4]. Thus, we present herein the synthesis of novel 1-(carbamoylmethyl)-2-aryl-3,1-benzoxazines, as a continuation of our ongoing project aimed at searching for novel fungicidal active compounds, by condensation reactions of 2-(N-substituted carbamoylmethylamino)benzyl alcohols with aldehydes in the presence of BF3·OEt2, and also report their fungicidal activities against plant fungi.

2. Results and Discussion

2.1. Chemistry

The synthetic route to the title compounds 5a–r is shown in Scheme 1. The key intermediate 2-(N-substituted carbamoylmethylamino)benzyl alcohols 3 (also named as: N-substituted 2-(2-(hydroxymethyl)phenylamino)acetamide) were prepared by selective N-alkylation of 2-aminobenzyl alcohol with N-substituted 2-bromoacetamide 2. The reaction exclusively occurred at the nitrogen atom giving products 3a–f (1H-NMR and 13C-NMR Data in Supplementary materials) in 65–73% yields when the reaction was carried out in a mixture solvent of N,N-dimethyl formamide (DMF) and tetrahydrofuran (THF) (v/v = 1:2) with potassium carbonate as base. Then, we began to synthesize the target products 5a–r (1H-NMR and 13C-NMR Data in Supplementary materials). The preparation of 5a was selected as model to optimize the reaction conditions. Firstly, reaction of 2-(N-(2-methylphenyl)carbamoylmethylamino)benzyl alcohol 3a with 3-nitrobenzaldehyde 4a in the presence of BF3·OEt2 (10% mol) in THF under 65 °C gave the desired product 5a in 35 yields (No. 1, Table 1). By optimizing the conditions, the yield was improved to 55% (No. 6). Under the same conditions, compounds 5b–r were synthesized in 40–85% yields. As shown in Table 1, for compounds with an amide nitrogen connected to the benzyl group, a higher yield was achieved than for those with a phenyl group (No. 16–18 vs. No. 13–15, Table 1), and moreover, the reaction yields of the former depended on the position of the nitro group on the benzene ring in order of para > ortho > meta. But, the yields for those with an amide nitrogen connected with an aryl group presented the order of meta > para > ortho.
The structures of the products were established on the basis of their spectroscopic data (IR, 1H-NMR, 13C-NMR) and elemental analysis. All compounds exhibit characteristic signals appropriately (see experimental section). This can be illustrated with compound 5a. In IR spectra, strong absorption at 1661 cm−1 corresponds to the stretching vibration of the C=O group; and absorption at 1586 and1536 cm−1 to the C=C bond. A singlet at 5.88 ppm observed in 1H-NMR spectra corresponds to OCHN proton of the benzoxazine ring. Particularly, the OCH2 protons within the benzoxazine ring absorb as two doublets at 4.74 and 4.97 ppm instead of singlet. These are characteristic signals indicating the formation of the benzoxazine ring [28]. Interestingly, the NCH2CO protons also absorb as two doublets at 3.88 and 4.13 ppm. A singlet at 2.06 ppm corresponds to CH3 protons. In 13C-NMR, a signal at 167.30 ppm corresponds to the C=O carbon, and signals at 88.59 and 64.74 ppm stand for the OCHN and OCH2 carbons, respectively. CH3 carbon absorbs at 17.37 ppm.

2.2. Fungicidal Activity Assay

According to standard method NY/T1156.5–2006 [29], the in vitro fungicidal activities of the prepared compounds 5a–r were evaluated, adopting the mycelium growth rate test method. The fungicidal activity was tested against Sclerotonia sclerotiorum, Botrytis cinerea, Rhizoctonia solani, Gibberella zeae and Phytophythora capsic at 25 µg/mL, and against Magnaporthe oryzae at 50 µg/mL. The activities were expressed as inhibition rate (%), and the results are summarized in Table 2. All compounds exhibited certain activities against the tested fungi, and some showed good activities. Compounds 5d and 5g showed 60.1% and 54.5% activity against M. oryzae, respectively, which are all higher than that of chlorothalonil (53.8%). The activity of compound 5o (51.7%) is closed to that of chlorothalonil. Compound 5i showed 71.9% activity against S. sclerotiorum at 25 µg/mL, which is close to that of chlorothalonil (84.9%). In addition, the compounds with the amide nitrogen atom connected with an aryl group were more active than those with a benzyl group. For S. sclerotiorum and R. solani, when the substituent at the 4-position of the benzene ring was connected with the amide nitrogen, the compounds with a NO2 group at the 4-position of the benzene ring exhibited higher activities than those with a NO2 group at 3- or 2-position.

3. Experimental Section

3.1. Materials and Reagents

All solvents were dried by standard procedure. Aromatic aldehydes, 2-aminobenzyl alcohol, and substituted anilines were commercially available. Infrared spectra were recorded on a Nicolet-6700 FT-IR. 1H- and 13C-NMR spectra were recorded on Bruker Avance-500 MHz spectrometer. Elemental analysis was measured on PE 2400 II CHNS instrument. Melting points were determined on a WRS-1B digital melting point instrument and uncorrected.

3.2. Chemical Synthesis

3.2.1. Synthesis of N-Substituted 2-(2-(hydroxymethyl)phenylamino)acetamides 3a–f

General Procedure: Into a 150 mL round bottom flask equipped with a condenser, N-(2-methylphenyl)-2-bromoacetamide (2.270 g, 10 mmol), 2-aminobenzyl alcohol (1.476 g, 12 mmol), potassium carbonate (1.932 g, 14 mmol) and mixed solvent of DMF and THF (45 mL, v:v = 1:2) were added with stirring. The mixture was heated at 65 °C for 12 h (checked by TLC). Then, the solvent was evaporated under reduced pressure. Saturated brine (50 mL) was added to the residue and extracted with ethyl acetate (3 × 50 mL). The organic phase was washed sequentially with water (2 × 50 mL), saturated brine (2 × 50 mL), and dried over Na2SO4, and filtered. The filtrate was evaporated under reduced pressure, the obtained residue purified by silica gel flash chromatography with ethyl acetate–petroleum ether (v/v = 1:2) as eluent, giving the product 3a (73% yield) as a white solid.
N-(2-Methylphenyl)-2-(2-(hydroxymethyl)phenylamino)acetamide (3a): Yield 73%. White solid, m.p.: 115.1–118.3 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.53 (s, 1H), 7.92 (d, J = 5 Hz,1H), 7.23–7.26 (m, 2H), 7.11 (d, J = 7.5 Hz, 2H), 7.09 (t, J = 7.5 Hz, 1H),6.79 (t, J = 7.0 Hz, 1H), 6.67 (d, J = 8.0 Hz, 1H), 5.66 (s, 1H), 4.76 (d, J = 5 Hz, 2H), 3.98 (s, 2H), 2.04 (s, 1H), 1.97 (s, 3H, -CH3); 13C-NMR (125 MHz, CDCl3) δ: 168.69, 146.20, 135.26, 131.52, 130.37, 129.91, 129.24, 126.80, 125.15, 125.00, 122.20, 118.84, 111.48, 64.75, 48.89, 17.11; IR (KBr, cm−1) ν: 3309, 3257, 1670, 1585, 1541, 1264, 1011, 748.
N-(4-Methylphenyl)-2-(2-(hydroxymethyl)phenylamino)acetamide (3b): Eluent: acetate/petroleum ether (v/v = 1:2); Yield 73%. White solid, m.p.: 123.4–124.5 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.51 (s, 1H), 7.33 (d, J = 8.0 Hz, 2H),7.20 (t, J = 8.0 Hz, 1H) 7.06–7.09 (m, 3H), 6.77 (t, J = 6.0 Hz, 1H), 6.58 (s, 1H), 5.52 (s, 1H), 4.72 (d, J = 5 Hz,2H), 3.86 (s, 2H), 2.28 (s,3H, -CH3); 13C-NMR (125 MHz, CDCl3) δ: 169.60, 146.40, 134.60, 134.39, 129.79, 129.48 (2C),129.41, 125.19, 120.31 (2C), 118.59, 111.30, 64.27, 48.87, 20.90; IR (KBr, cm−1) ν: 3398, 3321, 3229, 1677, 1609, 1552, 1525, 1313, 992, 818, 738.
N-(4-Methyloxyphenyl)-2-(2-(hydroxymethyl)phenylamino)acetamide (3c): Eluent: acetate/petroleum ether (v/v = 1:2); Yield 68%. Pale yellow solid, m.p.: 107.0–107.2 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.59 (s, H), 7.34 (d, J = 7.0Hz, 2H), 7.20 (s, 1H), 7.08 (s, 1H), 6.76–6.80 (m, 3H), 6.56 (t, J = 5.0 Hz, 1H), 5.51 (s, 1H), 4.69 (s, 2H), 3.83 (s, 2H), 3.74 (s, 3H, -OCH3); 13C-NMR (125 MHz, CDCl3) δ: 169.38, 156.62, 146.31, 130.17, 129.68, 129.30, 125.06, 121.97, 118.46, 114.00 (2C), 111.16, 64.21, 55.36, 48.67; IR (KBr, cm−1) ν: 3399, 3298, 1669, 1609, 1507, 1453, 1300, 1236, 1000, 825, 743.
N-(3-Methyloxyphenyl)-2-(2-(hydroxymethyl)phenylamino)acetamido (3d): Eluent: acetate/petroleum ether (v/v = 1:2); Yield 65%. Pale yellow solid, m.p.: 120.9–124.4 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.48 (s, 1H), 7.08–7.18 (m, 3H), 7.02 (d, J = 7.0 Hz, 1H), 6.87 (d, J = 8.0 Hz, 1H), 6.71 (t, J = 7.0 Hz, 1H), 6.56–6.58 (m, 1H), 6.52 (d, J = 8.0 Hz, 1H), 4.68 (s, 2H), 3.83 (s, 2H), 3.69 (s, 3H, -OCH3); 13C-NMR (125 MHz, CDCl3) δ: 169.36, 160.11, 146.44, 138.42, 129.96, 129.68, 129.36, 125.12, 118.83, 112.22, 111.51, 110.32, 105.85, 64.62, 55.34, 49.17; IR (KBr, cm−1) ν: 3391, 3336, 1672, 1601, 1560, 1516, 1455, 1430, 1050, 1006, 780, 749.
N-Phenyl-2-(2-(hydroxymethyl)phenylamino)acetamido (3e): Eluent: acetate/petroleum ether (v/v = 1:2); Yield 70%. White solid, m.p.: 117.2–119.3 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.59 (s, 1H), 7.45 (d, J = 8.0 Hz, 2H), 7.26 (t, J = 7.5 Hz, 2H), 7.19 (td, J = 8.0 Hz, 1.0 Hz, 1H), 7.08 (t, J = 6.5 Hz, 2H), 6.77 (t, J = 7.5 Hz, 1H), 6.57(d, J = 8.0 Hz, 1H), 5.52 (br, 1H), 4.72 (s, 2H), 3.86 (s, 2H), 2.77 (br, 1H); 13C-NMR (125 MHz, CDCl3) δ: 169.61, 146.39, 137.18, 129.87, 129.41, 129.00 (2C), 125.18, 124.70, 120.20 (2C), 118.72, 111.37, 64.41, 48.98; IR (KBr, cm−1) ν: 3342, 3265, 1678, 1608, 1563, 1513, 1498, 1444, 1313, 1254, 1003, 751.
N-Benzyl-2-(2-(hydroxymethyl)phenylamino)acetamido (3f): Eluent: acetate/petroleum ether (v/v = 1:2); Yield 66%. Pale yellow solid, m.p.: 107.7–108.8 °C; 1H-NMR (500 MHz, CDCl3) δ: 7.13–7.25 (m, 8H), 7.02 (d, J = 6.0 Hz, 1H), 6.73 (s, 1H, NH), 6.51 (s, 1H, NH), 4.60 (s, 2H), 4.37 (s, 2H), 3.77 (s, 2H); 13C-NMR (125 MHz, CDCl3) δ: 171.14, 146.48, 138.01, 129.63, 129.28, 128.62 (2C), 127.45 (2C), 127.41, 125.07, 118.27, 111.11, 64.35, 48.19, 43.01; IR (KBr, cm−1) ν: 3375, 3254, 1645, 1585, 1530, 1505, 1450, 1427, 1365, 1311, 1252, 1016, 751.

3.2.2. Synthesis of 2,4-Dihydro-1H-3,1-benzoxazines 5a–r

General Procedure: Under nitrogen, into a 100 mL three-necked round bottom flask equipped with a condenser, N-(2-methylphenyl)-2-(2-(hydroxymethyl)phenylamino)acetamide 3a (0.405 g, 1.5 mmol), 3-nitrobenzaldehyde (0.339 g, 2.25 mmol), THF (30 mL), BF3·OEt2 (0.031 g, 0.3 mmol) and molecular sieve 4Å (0.250 g) were added with stirring. The solution was heated at 65 °C for 10 h (checked by TLC). Then, the solvent was evaporated under reduced pressure. Ethyl acetate (70 mL) was added to the residue, and the obtained solution washed sequentially with water (2 × 40 mL) and saturated brine (2 × 40 mL). The organic phase was dried over Na2SO4 and filtered. The filtrate was evaporated under reduced pressure and the obtained residue purified by silica gel flash chromatography with ethyl acetate–petroleum ether (v/v = 1:5) as eluent, giving the product 5a (55% yield) as a yellow solid.
1-((2-Methylphenyl)carbamoylmethyl)-2-(3-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5a): Yield 55%. Yellow solid; m.p.: 151.2–152.2 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.50 (s, 1H), 8.34 (s, 1H), 8.23 (d, J = 9.0 Hz, 1H), 7.84 (d, J = 8.0 Hz, 1H), 7.78 (d, J = 7.5 Hz, 1H), 7.58 (t, J = 8.0 Hz, 1H), 7.24 (d, J = 7.0 Hz, 1H), 7.19 (t, J = 8.0 Hz, 1H), 7.13 (t, J = 7.0 Hz, 1H), 7.05 (t, J = 7.5 Hz, 1H), 6.93–6.97 (m, 3H), 5.88 (s, 1H, NCHO), 4.97 (d, J = 15 Hz, 1H), 4.74 (d, J = 15 Hz, 1H), 4.13 (d, J = 18 Hz, 1H), 3.88 (d, J = 18 Hz, 1H), 2.06 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.30 (C=O), 148.67, 141.92, 139.47, 135.04, 133.57, 130.53, 130.08, 128.70, 128.54, 126.86, 125.32, 125.09, 124.28, 122.82, 122.47, 122.23, 121.18, 115.20, 88.59, 64.74, 54.86, 17.37; IR (KBr, cm−1) ν: 3268, 1661 (C=O), 1586, 1536, 1497, 1458, 1397, 1346, 1259, 1208, 1070, 757, 733; Anal. Calcd. for C23H21N3O4: C, 68.47; H, 5.25; N, 10.42; Found: C, 68.16; H, 5.22; N, 10.37.
1-((2-Methylphenyl)carbamoylmethyl)-2-(2-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5b): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 45%. Yellow solid, m.p.: 162.6–162.9 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.51(s, 1H), 7.88 (d, J = 7.5 Hz, 1H), 7.78 (d, J = 8.0 Hz, 1H), 7.55–7.59 (m, 3H), 7.16–7.24 (m, 2H), 7.09 (d, J = 7.0 Hz, 1H), 7.03 (t, J = 7.0 Hz,1H), 6.89–6.91 (m, 3H), 6.44 (s, 1H, NCHO), 4.91 (d, J = 15 Hz, 1H), 4.61 (d, J = 15 Hz, 1H), 4.13 (d, J = 18 Hz, 1H) 3.96 (d, J = 18 Hz, 1H), 1.99 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.39 (C=O), 149.06, 141.80, 135.07, 133.07, 131.15, 130.50, 130.40, 129.34, 128.75, 128.58, 126.76, 125.24, 125.07, 125.05, 122.34, 121.99, 120.76, 114.34, 85.18, 65.30, 54.26, 17.29; IR (KBr, cm−1) ν: 3396, 2846, 1677 (C=O), 1606, 1533, 1515, 1499, 1466, 1459, 1354, 1326, 1186, 959, 759; Anal. Calcd. for C23H21N3O4: C, 68.47; H, 5.25; N, 10.42; Found: C, 68.75; H, 5.23; N, 10.38.
1-((2-Methylphenyl)carbamoylmethyl)-2-(4-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5c): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 49%. Yellow solid, m.p.: 153.4–153.8 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.47 (s, 1H), 8.24 (d, J = 8.5 Hz, 2H), 7.84 (d, J = 8.0 Hz, 1H), 7.62 (d, J = 8.5 Hz, 2H), 7.18–7.25 (m, 2H), 7.13 (d, J = 7.5 Hz, 1H), 7.06 (t, J = 7.5 Hz, 1H), 6.93–6.96 (m, 3H), 5.89 (s, 1H, NCHO), 4.94 (d, J = 15 Hz, 1H), 4.69 (d, J = 15 Hz, 1H), 4.14 (d, J = 18 Hz, 1H), 3.88 (d, J = 18 Hz, 1H), 2.03 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.28 (C=O), 148.42, 144.07, 141.68, 135.03, 130.54, 128.68 (3C), 128.50, 126.90, 125.36, 125.12, 124.15 (2C), 122.36, 122.29, 121.06, 114.90, 88.52, 64.46, 54.78, 17.39; IR (KBr, cm−1) ν: 3308, 1663 (C=O), 1608, 1585, 1531, 1502, 1459, 1354, 1291, 1257, 1080, 859, 741; Anal. Calcd. for C23H21N3O4: C, 68.47; H, 5.25; N, 10.42; Found: C, 68.15; H, 5.27; N, 10.46.
1-((4-Methylphenyl)carbamoylmethyl)-2-(3-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5d): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 56%. Yellow solid, m.p.: 168.5–169.1 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.49 (s, 1H), 8.31 (s, 1H), 8.13 (d, J = 8.0 Hz, 1H), 7.72 (d, J = 8.0 Hz, 1H), 7.49 (t, J = 8.0 Hz, 1H), 7.25 (d, J = 8.0 Hz, 2H), 7.16–7.19 (m, 1H), 7.03 (d, J = 8.0 Hz, 2H), 6.88 (d, J = 6.5 Hz, 2H), 6.85 (d, J = 6.5 Hz, 1H), 5.76 (s, 1H, NCHO), 4.96 (d, J = 15Hz, 1H), 4.72 (d, J = 15 Hz, 1H), 3.92 (d, J = 18 Hz, 1H), 3.78 (d, J = 18 Hz, 1H), 2.22 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.36 (C=O), 148.64, 142.61, 139.42, 134.48, 134.44, 133.57, 130.05, 129.57 (2C), 128.65, 124.99, 124.31, 122.80 (2C), 121.41, 119.84 (2C), 115.95, 88.81, 65.27, 55.33, 20.89; IR (KBr, cm−1) ν: 3318, 1681 (C=O), 1602, 1528, 1505, 1349, 1309, 1257, 1241, 1056, 964, 814, 739; Anal. Calcd. for C23H21N3O4: C, 68.47; H, 5.25; N, 10.42; Found: C, 68.13; H, 5.27; N, 10.48.
1-((4-Methylphenyl)carbamoylmethyl)-2-(2-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5e): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 40%. Yellow solid, m.p.: 136.0–138.5 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.65 (s, 1H), 7.81 (d, J = 8.0 Hz, 1H), 7.64 (d, J = 8.0 Hz, 1H), 7.54 (t, J = 7.5 Hz, 1H), 7.45 (t, J = 7.5 Hz, 1H), 7.27 (d, J = 8.5 Hz, 2H), 7.15–7.19 (m, 1H), 7.01 (d, J = 7.0 Hz, 2H), 6.88 (d, J = 3.5 Hz, 2H), 6.83 (d, J = 8.5 Hz, 1H), 6.28 (s, 1H, NCHO), 4.94 (d, J = 15 Hz, 1H), 4.67 (d, J = 15 Hz, 1H), 3.92 (d, J = 18 Hz, 1H), 3.86 (d, J = 18 Hz, 1H), 2.22 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.67 (C=O), 148.88, 143.17, 134.66, 134.24, 133.18, 131.02, 130.40, 129.55, 129.49 (2C), 128.47, 124.99, 124.94, 122.92, 121.42, 119.75 (2C), 116.10, 85.39, 66.14, 55.03, 20.90; IR (KBr, cm−1) ν: 3337, 2919, 1671 (C=O), 1587, 1524, 1488, 1455, 1352, 1206, 1029, 923, 738; Anal. Calcd. for C23H21N3O4: C, 68.47; H, 5.25; N, 10.42; Found: C, 68.90; H, 5.22; N, 10.36.
1-((4-Methylphenyl)carbamoylmethyl)-2-(4-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5f): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 48%. Yellow solid, m.p.: 157.2–158.5 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.53 (s, 1H), 8.22 (d, J = 8.5 Hz, 2H), 7.64 (d, J = 8.5 Hz, 2H), 7.31 (d, J = 8.5 Hz, 2H), 7.21–7.25 (m, 1H), 7.10 (d, J = 8.0 Hz, 2H), 6.93–6.95 (m, 3H), 5.85 (s, 1H, NCHO), 4.99 (d, J = 15 Hz, 1H), 4.75 (d, J = 15 Hz, 1H), 4.03 (d, J = 18Hz, 1H), 3.85 (d, J = 18 Hz, 1H), 2.30 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.38 (C=O), 148.38, 144.01, 142.34, 134.52, 134.49, 129.59 (2C), 128.66 (2C), 128.63, 125.04, 124.13 (2C), 122.78, 121.34, 119.83 (2C), 115.77, 88.68, 64.88, 55.34, 20.89; IR (KBr, cm−1) ν: 3369, 2973, 1672 (C=O), 1605, 1519, 1348, 1329, 1191, 1067, 966, 813, 745; Anal. Calcd. for C23H21N3O4: C, 68.47; H, 5.25; N, 10.42; Found: C, 68.08; H, 5.22; N, 10.47.
1-((4-Methyloxyphenyl)carbamoylmethyl)-2-(3-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5g): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 85%. Yellow solid, m.p.: 167.0–167.2 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.49 (s, 1H), 8.31 (s, 1H), 8.13 (d, J = 8.0 Hz, 1H), 7.72 (d, J = 7.5 Hz, 1H), 7.49 (t, J = 8.0 Hz, 1H), 7.25 (d, J = 7.5 Hz, 2H), 7.18 (t, J = 6.5 Hz, 1H), 7.02 (d, J = 8.0 Hz, 2H), 6.84–6.88 (m, 3H), 5.76 (s, 1H, NCHO), 4.96 (d, J = 15Hz, 1H), 4.71 (d, J = 15 Hz, 1H), 3.91 (d, J = 18 Hz, 1H), 3.77 (d, J = 18 Hz, 1H), 2.22 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.36 (C=O), 148.63, 142.62, 139.42, 134.47, 134.45, 133.59, 130.06, 129.57 (2C), 128.65, 124.99, 124.31, 122.80 (2C), 121.40, 119.84 (2C), 115.95, 88.81, 65.29, 55.32, 20.91; IR (KBr, cm−1) ν: 3319, 1682 (C=O), 1603, 1527, 1504, 1444, 1404, 1350, 1309, 1257, 1242, 1179, 1057, 965, 931, 814, 740; Anal. Calcd. for C23H21N3O5: C, 65.86; H, 5.05; N, 10.02; Found: C, 65.56; H, 5.03; N, 10.06.
1-((4-Methyloxyphenyl)carbamoylmethyl)-2-(2-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5h): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 66%. Yellow solid, m.p.: 156.1–158.2 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.67 (s, 1H), 7.89 (d, J = 8.0 Hz, 1H), 7.70 (d, J = 7.5 Hz, 1H), 7.62 (t, J = 7.5 Hz, 1H), 7.53 (t, J = 7.5 Hz, 1H), 7.36 (d, J = 9.0 Hz, 2H), 7.22–7.23 (m, 1H), 6.96 (d, J = 4.5 Hz, 2H), 6.92 (d, J = 8.5 Hz, 1H), 6.83 (d, J = 9.0 Hz, 2H), 6.36 (s, 1H, NCHO), 5.01 (d, J = 15 Hz, 1H), 4.74 (d, J = 15 Hz, 1H), 3.99 (d, J = 15 Hz, 1H), 3.93 (d, J = 15 Hz, 1H), 3.77 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.53 (C=O), 156.67, 148.88, 143.15, 133.17, 131.03, 130.40, 130.37, 129.56, 128.46, 124.99, 124.95, 122.89, 121.47 (2C), 121.39, 116.04, 114.14 (2C), 85.38, 66.11, 55.49, 54.93; IR (KBr, cm−1) ν: 3339, 2942, 1674 (C=O), 1605, 1531, 1506, 1465, 1405, 1346, 1316, 1246, 1175, 1038, 962, 839, 744; Anal. Calcd. for C23H21N3O5: C, 65.86; H, 5.05; N, 10.02; Found: C, 65.46; H, 5.08; N, 9.97.
1-((4-Methyloxyphenyl)carbamoylmethyl)-2-(4-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5i): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 80%. Pale yellow solid, m.p.: 156.6–158.5 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.42 (s, 1H), 8.16 (d, J = 8.5 Hz, 2H), 7.57 (d, J = 8.5 Hz, 2H), 7.26 (d, J = 9.0 Hz, 2H), 7.15–7.19 (m, 1H), 6.85–6.88 (m, 3H), 6.76 (d, J = 9.0 Hz, 2H), 5.78 (s, 1H, NCHO), 4.92 (d, J = 15 Hz, 1H), 4.66 (d, J = 15 Hz, 1H), 3.96 (d, J = 18 Hz, 1H), 3.78 (d, J = 18 Hz, 1H), 3.71 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.22 (C=O), 156.75, 148.39, 144.00, 142.30, 130.61, 130.13, 128.65 (2C), 125.04, 124.14 (2C), 122.72, 121.58 (2C), 121.31, 115.69, 114.25 (2C), 88.67, 64.84, 55.51, 55.24; IR (KBr, cm−1) ν: 3379, 2934, 1684 (C=O), 1601, 1523, 1494, 1347, 1307, 1264, 1240, 1039, 865, 763; Anal. Calcd. for C23H21N3O5: C, 65.86; H, 5.05; N, 10.02; Found: C, 66.24; H, 5.02; N, 10.07.
1-((3-Methyloxyphenyl)carbamoylmethyl)-2-(3-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5j): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 74%. Pale yellow solid, m.p.: 56.6–58.4 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.65 (s, 1H), 8.39 (s, 1H), 8.21 (d, J = 8.0 Hz, 1H), 7.80 (d, J = 7.5 Hz, 1H), 7.58 (t, J = 7.5 Hz, 1H), 7.18–7.26 (m, 3H), 6.92–6.97 (m, 4H), 6.66 (d, J = 8.0 Hz, 1H), 5.84 (s, 1H, NCHO), 5.04 (d, J = 15 Hz, 1H), 4.80 (d, J = 15 Hz, 1H) ,4.00 (d, J = 18 Hz, 1H), 3.85 (d, J = 18 Hz, 1H), 3.79 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.60 (C=O), 160.17, 148.62, 142.57, 139.36, 138.21, 133.62, 130.13, 129.83, 128.70, 125.05, 124.37, 122.87, 122.79, 121.55, 116.09, 111.87, 110.61, 105.41, 88.81, 65.29, 55.50, 55.39; IR (KBr, cm−1) ν: 3327, 3078, 2937, 2837, 1674 (C=O), 1606, 1530, 1494, 1458, 1349, 1290, 1220, 1155, 1085, 1046, 960, 754; Anal. Calcd. for C23H21N3O5: C, 65.86; H, 5.05; N, 10.02; Found: C, 65.52; H, 5.07; N, 9.98.
1-((3-Methyloxyphenyl)carbamoylmethyl)-2-(2-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5k): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 41%. Brown yellow solid, m.p.: 50.9–52.4 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.73 (s, 1H), 7.80 (d, J = 8.0 Hz, 1H), 7.64 (d, J = 8.0 Hz, 1H), 7.54 (t, J = 7.5 Hz, 1H), 7.44 (t, J = 8.0 Hz, 1H), 7.18 (s, 1H), 7.12–7.15 (m, 2H), 7.09 (d, J = 8.0 Hz, 1H), 6.86–6.88 (m, 2H), 6.83 (d, J = 8.0 Hz, 1H), 6.57 (d, J = 8.0 Hz, 1H), 6.27 (s, 1H, NCHO), 4.94 ( d, J = 15 Hz, 1H), 4.67 (d, J = 15 Hz, 1H), 3.87 (d, J = 5 Hz, 2H), 3.70 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 168.00 (C=O), 160.12, 148.84, 143.23, 138.40, 133.26, 130.98, 130.46, 129.73, 129.60, 128.50, 125.03, 124.99, 123.06, 121.59, 116.31, 111.88, 110.44, 105.38, 85.44, 66.21, 55.36, 55.19; IR (KBr, cm−1) ν: 3361, 2974, 2895, 1680 (C=O), 1607, 1532, 1494, 1457, 1377, 1088, 1049, 881, 753; Anal. Calcd. for C23H21N3O5: C, 65.86; H, 5.05; N, 10.02; Found: C, 65.55; H, 5.03; N, 10.06.
1-((3-methyloxyphenyl)carbamoylmethyl)-2-(4-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5l): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 60%. Yellow solid, m.p.: 128.7–129.9 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.54 (s, 1H), 8.14 (d, J = 8.5 Hz, 2H),7.56(d,J =8.5 Hz, 2H), 7.13–7.18 (m, 2H), 7.10 (d, J = 8.0 Hz, 1H), 6.81–6.87 (m, 4H), 6.58 (td, J = 8.0, 2.0 Hz, 1H), 5.78 (s, 1H, NCHO), 4.92 (d, J = 15 Hz, 1H), 4.67 (d, J = 15 Hz, 1H), 3.96 (d, J = 18 Hz, 1H), 3.78 (d, J = 18 Hz, 1H) ,3.70 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.63 (C=O), 160.20, 148.35, 143.99, 142.30, 138.30, 129.80, 128.67 (2C), 128.62, 125.07, 124.13 (2C), 122.85, 121.40, 115.86, 111.85, 110.39, 105.64, 88.65, 64.88, 55.44, 55.35; IR (KBr, cm−1) ν: 3366, 1666 (C=O), 1602, 1593, 1520, 1456, 1434, 1348, 1330, 1270, 1157, 1073, 1052, 972, 855, 776; Anal. Calcd. for C23H21N3O5: C, 65.86; H, 5.05; N, 10.02; Found: C, 66.15; H, 5.03; N, 9.99.
2-(3-Nitrophenyl)-1-(phenylcarbamoylmethyl)-2,4-dihydro-1H-3,1-benzoxazine (5m): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 52%. Yellow solid, m.p.: 130.6–131.5 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.59 (s, 1H), 8.35 (s, 1H), 8.18 (d, J = 8.0 Hz, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.53 (t, J = 8.0 Hz, 2H), 7.42 (d, J = 8.0 Hz, 2H), 7.27 (t, J = 7.5 Hz, 2H), 7.19–7.23 (m, 1H), 7.08 (t, J = 7.5 Hz, 1H), 6.90–6.94 (m, 2H), 5.81 (s, 1H, NCHO), 5.01 (d, J = 15 Hz, 1H), 4.76 (d, J = 15 Hz, 1H), 3.99 (d, J = 18 Hz, 1H), 3.84 (d, J = 15 Hz, 1H); 13C-NMR (125 MHz, CDCl3) δ: 167.61 (C=O), 148.68, 142.59, 139.42, 137.05, 133.61, 130.11, 129.14 (2C), 128.71, 125.06, 124.83, 124.35, 122.89, 122.83, 121.52, 119.83 (2C), 116.05, 88.84, 65.27, 55.44; IR (KBr, cm−1) ν: 3302, 3069, 1669 (C=O), 1602, 1532, 1496, 1444, 1349, 1301, 1256, 1174, 1079, 751; Anal. Calcd. for C22H19N3O4: C, 67.86; H, 4.92; N, 10.79; Found: C, 67.59; H, 4.90; N, 10.75.
2-(2-Nitrophenyl)-1-(phenylcarbamoylmethyl)-2,4-dihydro-1H-3,1-benzoxazine (5n): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 44%. Yellow solid, m.p.: 157.5–158.8 °C; 1H-NMR (500 MHz, CDCl3), δ: 8.73 (s, 1H), 7.80 (d, J = 8.5 Hz, 1H), 7.64 (d, J = 8.0 Hz, 1H), 7.53 (t, J = 7.5 Hz, 1H), 7.44 (t, J = 7.5 Hz, 1H), 7.39 (d, J = 8.0 Hz, 2H), 7.18–7.23 (m, 2H), 7.12–7.14 (m, 1H), 7.02 (t, J = 7.5 Hz, 1H), 6.86 (d, J = 4.5 Hz, 2H), 6.84 (d, J = 8.0 Hz, 1H), 6.28 (s, 1H, NCHO), 4.95 (d, J = 15 Hz, 1H), 4.67 (d, J = 15 Hz, 1H), 3.93 (d, J = 18 Hz, 1H), 3.88 (d, J = 18 Hz, 1H); 13C-NMR (125 MHz, CDCl3) δ: 167.95 (C=O), 148.91, 143.17, 137.25, 133.23, 131.01, 130.46, 129.61, 129.05 (2C), 128.52, 125.02 (2C), 124.63, 123.00, 121.53, 119.76 (2C), 116.18, 85.46, 66.16, 55.13; IR (KBr, cm−1) ν: 3316, 3207, 1676 (C=O), 1603, 1553, 1528, 1495, 1441, 1346, 1311, 1252, 1197, 1075, 750; Anal. Calcd. for C22H19N3O4: C, 67.86; H, 4.92; N, 10.79; Found: C, 67.54; H, 4.90; N, 10.74.
2-(4-Nitrophenyl)-1-(phenylcarbamoylmethyl)-2,4-dihydro-1H-3,1-benzoxazine (5o): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 46%. Yellow solid, m.p.: 142.6–144.0 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.66 (s, 1H), 8.22 (d, J = 8.5 Hz, 2H), 7.64 (d, J = 8.5 Hz, 2H), 7.44 (d, J = 7.5 Hz, 2H), 7.30 (t, J = 8.0 Hz, 2H), 7.21–7.25 (m, 1H), 7.12 (t, J = 7.5 Hz, 1H), 6.92–6.95 (m, 3H), 5.86 (s, 1H, NCHO), 5.01 (d, J = 15 Hz, 1H), 4.75 (d, J = 15 Hz, 1H), 4.05 (d, J = 18 Hz, 1H), 3.86 (d, J = 18Hz, 1H); 13C-NMR (125 MHz, CDCl3) δ: 167.56 (C=O), 148.46, 143.99, 142.29, 137.10, 129.19 (2C), 128.73, 128.70 (2C), 125.13, 124.88, 124.23 (2C), 122.87, 121.51, 119.79 (2C), 115.91, 88.75, 64.90, 55.52; IR (KBr, cm−1) ν: 3365, 1666 (C=O), 1600, 1519, 1444, 1350, 1331, 1263, 853, 762; Anal. Calcd. for C22H19N3O4: C, 67.86; H, 4.92; N, 10.79; Found: C, 67.55; H, 4.94; N, 10.83.
1-(Benzylcarbamoylmethyl)-2-(3-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5p): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 56%. Yellow solid, m.p.: 103.3–105.7 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.28 (s, 1H), 8.20 (d, J = 8.0 Hz, 1H), 7.68 (d, J = 7.5 Hz, 1H), 7.48 (t, J = 8.0 Hz, 1H), 7.22–7.26 (m, 4H), 7.15 (s, 1H), 7.07–7.09 (m, 2H), 6.92–6.93 (m, 2H), 6.85 (d, J = 8.0 Hz, 1H), 5.75 (s, 1H, NCHO), 4.91 (d, J = 15 Hz, 1H), 4.69 (d, J = 15 Hz, 1H), 4.49 (dd, J = 14.5, 6.0 Hz, 1H), 4.32 (dd, J = 14.5, 5.0 Hz, 1H), 3.95 (d, J = 18 Hz, 1H), 3.78 (d, J = 18 Hz, 1H); 13C-NMR (125 MHz, CDCl3) δ: 169.25 (C=O), 148.56, 142.52, 139.52, 137.69, 133.65, 130.00, 128.75 (2C), 128.53, 127.62, 127.56 (2C), 124.96, 124.26, 122.85, 122.47, 120.96, 115.43, 88.80, 65.24, 54.46, 43.37; IR (KBr,cm-1) ν: 3329, 1650 (C=O), 1530, 1494, 1459, 1426, 1353, 1328, 1248, 1084, 744; Anal. Calcd. for C23H21N3O4: C, 68.47; H, 5.25; N, 10.42; Found: C, 68.09; H, 5.22; N, 10.37.
1-(Benzylcarbamoylmethyl)-2-(2-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5q): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 58%. Yellow solid, m.p.: 96.2–97.3 °C; 1H-NMR (500 MHz, CDCl3) δ: 7.82 (s, 1H), 7.47–7.53 (m, 3H), 7.21–7.25 (m, 4H), 7.05 (d, J = 4.5 Hz, 2H), 6.88–6.91 (m, 2H), 6.84 (d, J = 8.0 Hz, 1H), 6.32 (s, 1H, NCHO), 4.84 (d, J = 15.0 Hz, 1H), 4.57 (d, J = 15.0 Hz, 1H), 4.52 (dd, J = 15.0, 7.0 Hz, 1H), 4.27 (dd, J = 15.0, 5.0 Hz, 1H), 4.03 (d, J = 18.0 Hz, 1H), 3.89 (d, J = 18.0 Hz, 1H); 13C-NMR (125 MHz, CDCl3) δ: 169.42 (C=O), 148.95, 142.46, 137.84, 133.02, 131.15, 130.24, 129.46, 128.64 (2C), 128.39, 127.49 (2C), 127.41, 124.91 (2C), 122.20, 120.67, 114.97, 85.14, 65.48, 54.20, 43.18; IR (KBr, cm−1) ν: 3394, 1675 (C=O), 1607, 1530, 1501, 1466, 1358, 1325, 1263, 1188, 1067, 960, 847, 755; Anal. Calcd. for C23H21N3O4: C, 68.47; H, 5.25; N, 10.42; Found: C, 68.13; H, 5.23; N, 10.38.
1-(Benzylcarbamoylmethyl)-2-(4-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5r): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 65%. Yellow solid, m.p.: 147.7–148.5 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.03 (d, J = 8.5 Hz, 2H), 7.45 (d, J = 8.5 Hz, 2H), 7.14–7.20 (m, 4H), 7.05 (br, 1H, NH), 6.99–7.01 (m, 2H), 6.82–6.85 (m, 2H), 6.77 (d, J = 8.5 Hz, 1H), 5.67 (s, 1H, NCHO), 4.81 (d, J = 15 Hz, 1H), 4.59 (d, J = 15 Hz, 1H), 4.4 (dd, J = 15.0, 7.0 Hz, 1H), 4.22 (dd, J = 15.0, 5.0 Hz, 1H), 3.86 (d, J = 18.0 Hz, 1H), 3.69 (d, J = 18.0 Hz, 1H); 13C-NMR (125 MHz, CDCl3) δ: 169.15 (C=O), 148.31, 144.11, 142.51, 137.75, 128.72 (2C), 128.67 (2C), 128.48, 127.69, 127.62 (2C), 124.95, 124.06 (2C), 122.49, 120.89, 115.33, 88.78, 65.06, 54.52, 43.32; IR (KBr, cm−1) ν: 3405, 1681 (C=O), 1604, 1518, 1495, 1463, 1425, 1347, 1298, 1074, 1027, 857, 761; Anal. Calcd. for C23H21N3O4: C, 68.47; H, 5.25; N, 10.42; Found: C, 68.20; H, 5.23; N, 10.39.

3.3. Fungicidal Activity Testing

The in vitro inhibition of mycelium in the agar culture medium caused by the title compounds against six phytopathogenic fungi: Sclerotonia sclerotiorum, Botrytis cinerea, Rhizoctonia solani, Gibberella zeae, Phytophythora capsic and Magnaporthe oryzae was performed. Referring to the standard method NY/T1156.5–2006, antifungal activity assays adopted the mycelium growth rate test method. Chlorothalonil was used as a reference compound. A stock solution of every test compound was prepared in acetone and then diluted to the required test concentrations (500 µg/mL) with sorporl-144 (concentration: 200 µg/mL). Solutions of the test compounds (1 mL) were added to potato dextrose agar (PDA) medium (9 mL, 45 °C) to provide the final concentration of 25 µg/mL, but 50 µg/mL for Magnaporthe oryzae. The mixed medium without sample was used as the blank control. The inocula, 4 mm in diameter, were removed from the margins of actively growing colonies of mycelium and placed in the centers of the above plates. 4 replicates were performed per treatment. Percentages of growth inhibition were calculated by comparing the mean value of the diameters of the mycelia in the test plates after placement in a 24 °C biochemical incubator thermostat for 3 days. The inhibition percent was calculated according to the following equation:
I = [(D1 − D0)/D1–4] × 100%
where I is the inhibition rate, D1 is the average diameter of mycelia the blank test, and D0 is the average diameter of mycelia in the presence of compounds. The results are given in Table 2.

4. Conclusions

In summary, we have prepared a series of novel 1-(carbamoylmethyl)-2-aryl-3,1-benzoxazines by aza-acetalizations of 2-(N-substituted carbamoylmethylamino)benzyl alcohols with aromatic aldehydes in the presence of BF3·OEt2. The fungicidal activities of the prepared compounds against plant fungi were preliminarily evaluated, and some compounds showed good activities. Compounds 5d and 5g showed higher activity against M. Oryzae than chlorothalonil. The activity of compound 5i against S. Sclerotiorum is close to that of chlorothalonil.

Supplementary Materials

Supplementary materials are available online: 1H-NMR and 13C-NMR Data for compounds 3a–3f, 5a–5r.

Acknowledgments

The authors thank the National Natural Science Foundation of China (21372070), the Scientific Research Fund of Hunan Provincial Education Department (17A066), and the Open Project of the Key Laboratory of Theoretical Organic Chemistry and Functional Molecule of Ministry of Education (LKF1506) for the financial support of this work.

Author Contributions

Z.-L.T.: Conceived, designed the compounds, experiments, analysis of spectral data and writing the paper. L.W.: Synthesis of compounds and analysis of spectral data. J.-Z.T.: Synthesis of compounds and aid in the analysis of spectral data and manuscript preparation. Y.-C.W.: Analysis of biological results. Y.-C.J.: Analysis of spectral data of compounds.

Conflicts of Interest

The authors declare no conflict of interest. All authors read and approved the final manuscript.

References

  1. Kuch, H.; Schmitt, K.; Seudl, G.; Hoffmann, I. 2-Amino-4,4-di-substituted-4H-3,1-benzoxazines. U.S. Patent 3725404, 3 April 1973. [Google Scholar]
  2. Kobzina, J.W.; Creek, W. Herbicidal N-Haloacetyl-1,2-dihydro-4H-3,1-benzoxazine. U.S. Patent 4030906, 21 June 1977. [Google Scholar]
  3. Sugiyama, H.; Hosoda, K.; Kumagai, Y.; Takeuchi, M.; Okada, M. 4H-3,1-Benzoxazine Derivatives, Process for Producing the Same and Agricultural or Horticultural Fungicide Containing the Same. U.S. Patent 4596801, 24 June 1986. [Google Scholar]
  4. Tang, Z.; Wang, L.; Huang, T.; Gao, W.; Luo, X. The Fungicidal Activities and Application of 1-(Carbamoylmethyl)-2-aryl-2,4-dihydro-3,1-benzoxazines. CN104910094A, 16 September 2015. [Google Scholar]
  5. Charmantray, F.; Demeunynck, M.; Carrez, D.; Croisy, A.; Lansiaux, A.; Bailly, C.; Colson, P. 4-Hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agents. J. Med. Chem. 2003, 46, 967–977. [Google Scholar] [CrossRef] [PubMed]
  6. Zhang, P.; Terefenko, E.A.; Fensome, A.; Zhang, Z.; Zhu, Y.; Cohen, J.; Winneker, R.; Wrobel, J.; Yardley, J. Potent nonsteroidal progesterone receptor agonists: Synthesis and SAR study of 6-aryl-benzoxazines. Bioorg. Med. Chem. Lett. 2002, 12, 787–790. [Google Scholar] [CrossRef]
  7. Dias, N.; Goossens, J.; Baldeyrou, B.; Lansiaux, A.; Colson, P.; Di Salvo, A.; Bernal, J.; Turnbull, A.; Mincher, D.J.; Bailly, C. Oxoazabenzo[de]anthracenes conjugated to amino acids: Synthesis and evaluation as DNA-binding antitumor agents. Bioconj. Chem. 2005, 16, 949–958. [Google Scholar] [CrossRef] [PubMed]
  8. Clark, R.D.; Caroon, J.M.; Kluge, A.F.; Repke, D.B.; Roszkowski, A.P.; Strosberg, A.M.; Baker, S.; Bitter, S.M.; Okada, M.D. Synthesis and antihypertensive activity of 4′-substituted spiro[4H-3,1-benzoxazine-4,4’-piperidin]-3(1H)-ones. J. Med. Chem. 1983, 26, 657–661. [Google Scholar] [CrossRef] [PubMed]
  9. Badolato, M.; Carullo, G.; Armentano, B.; Panza, S.; Malivindi, R.; Aiello, F. Synthesis and anti-proliferative activity of a small library of 7-substituted 5H-pyrrole [1,2-a][3,1]benzoxazin-5-one derivatives. Bioorg. Med. Chem. Lett. 2017, 27, 3092–3095. [Google Scholar] [CrossRef] [PubMed]
  10. Zhang, P.; Terefenko, E.A.; Fensome, A.; Wrobel, J.; Winneker, R.; Lundeen, S.; Marschke, K.B.; Zhang, Z. 6-Aryl-1,4-dihydro-benzo[d][1,3]oxazin-2-ones: A novel class of potent, selective, and orally active nonsteroidal progesterone receptor antagonists. J. Med. Chem. 2002, 45, 4379–4382. [Google Scholar] [CrossRef] [PubMed]
  11. Kern, J.C.; Terefenko, E.A.; Fensome, A.; Unwallla, R.; Wrobel, J.; Zhu, Y.; Cohen, J.; Winneker, R.; Zhang, Z.; Zhang, P. SAR studies of 6-(arylamino)-4,4-disubstituted-1-methyl-1,4-dihydro-benzo[d][1,3]-oxazin-2-ones as progesterone. Bioorg. Med. Chem. Lett. 2007, 17, 189–192. [Google Scholar] [CrossRef] [PubMed]
  12. Krantz, A.; Spencer, R.W.; Tam, T.F.; Liak, T.J.; Copp, L.J.; Thomas, E.M.; Rafferty, S.P. Design and synthesis of 4H-3,1-benzoxazin-4-one as potent alternate substrate inhibitors of human leukocyte elastase. J. Med. Chem. 1990, 33, 464–479. [Google Scholar] [CrossRef] [PubMed]
  13. Gilmore, J.L.; Hays, S.J.; Caprathe, B.W.; Lee, C.; Emmerling, M.R.; Micheal, W.; Jean, J.C. Synthesis and valuation of 2-aryl-4H-3,1-benzoxazin-4-ones as C1r serine protease inhibitors. Bioorg. Med. Chem. Lett. 1996, 6, 679–682. [Google Scholar] [CrossRef]
  14. Hays, S.J.; Caprathe, B.W.; Gilmore, J.L.; Amin, N.; Emmerling, M.R.; Micheal, W.; Nadimpalli, R.; Nath, R.; Raser, K.J.; Stafford, D.; et al. 2-Amino-4H-3,1-benzoxazi-4-ones as C1r serine protease. J. Med. Chem. 1998, 41, 1060–1067. [Google Scholar] [CrossRef] [PubMed]
  15. Gutschow, M.; Neumann, U.; Sieler, J.; Eger, K. Studies on 2-benzyloxy-4H-3,1-bnezoxazin-4-ones as serine protease inhibitors. Pharm. Acta Helv. 1998, 73, 95–103. [Google Scholar] [CrossRef]
  16. Mizutani, T.; Ishikawa, S.; Nagase, T.; Takahashi, H.; Fujimura, T.; Sasaki, T.; Nagumo, A.; Shimamura, K.; Miyamoto, Y.; Kitazawa, H.; et al. Discovery of novel benzoxazinones as potent and orally active long chain fatty acid elongase 6 inhibitors. J. Med. Chem. 1990, 52, 7289–7300. [Google Scholar] [CrossRef] [PubMed]
  17. Hanessian, S.; Jennequin, T.; Boyer, N.; Babonneau, V.; Soma, U.; La Cour, C.M.; Millan, M.J.; De Nanteuil, G. Design, synthesis, and optimization of balanced dual NK1/NK3 receptor antagonists. ACS Med. Chem. Lett. 2014, 5, 550–555. [Google Scholar] [CrossRef] [PubMed]
  18. Marasini, B.P.; Rahim, F.; Perveen, S.; Karim, A.; Khan, K.M.; Rahman, A.; Choudhary, M.L. Synthesis, structure-activity relationships studies of benzoxazine derivatives as α-chymoitrypsin inhibitor. Bioorg. Chem. 2017, 70, 210–221. [Google Scholar] [CrossRef] [PubMed]
  19. Martin-Martinez, M.; Perez-Gordillo, F.; Alvarez de la Rosa, D.; Rodriguez, Y.; Gerona-Navarro, G.; Gonzalez-Muniz, R.; Zhou, M.-M. Modulating mineralocorticoid receptor with non-steroidal antagonists. New opportunities for the development of potent and selective ligands without off-target side effects. J. Med. Chem. 2017, 60, 2629–2650. [Google Scholar] [CrossRef] [PubMed]
  20. Patel, M.; Ko, S.S.; McHugh, R.J.; Markwalder, J.A.; Srivasta, A.S.; Cordova, B.C.; Klabe, R.M.; Erickson-Viitanen, S.; Trainor, G.L.; Seitz, S.P. Synthesis and evaluation of analogs of Efavirenz (SustivaTM) as HIV-1 reverse transcriptase inhibitors. Bioorg. Med. Chem. Lett. 1999, 9, 2805–2810. [Google Scholar] [CrossRef]
  21. Cocuzza, A.J.; Chidester, D.R.; Cordova, B.C.; Jeffrey, S.; Parsons, R.L.; Bacheler, L.T.; Erickson-Viitanen, S. Synthesis and evaluation of Efavirenz (SustivaTM) analogues as HIV-1 reverse transcriptase inhibitors: Replacement of the cyclopropylacetylene side chain. Bioorg. Med. Chem. Lett. 2001, 11, 1177–1179. [Google Scholar] [CrossRef]
  22. Holly, F.W.; Cope, A.C. Condensation products of aldehydes and ketones with o-aminobenzyl alcohol and o-hydroxybenzylamine. J. Am. Chem. Soc. 1944, 66, 1875–1879. [Google Scholar] [CrossRef]
  23. Nguyen, T.T.; Amey, R.L.; Martin, J.C. Tridentate ligand useful in stabilizing coordination states of nonmetallic elements. An aryldialkoxydifluoroperiodinane. J. Org. Chem. 1982, 47, 1024–1207. [Google Scholar] [CrossRef]
  24. Saito, T.; Ogawa, S.; Takei, N.; Kutsumura, N.; Otani, T. Palladium-catalyzed highly regio- and stereoselective synthesis of 4-alkylidene-4H-3,1-benzoxazines from N-acyl-o-alkynylanilines. Org. Lett. 2011, 13, 1098–1101. [Google Scholar] [CrossRef] [PubMed]
  25. Zhang, N.; Cheng, R.; Zhang-Negrerie, D.; Du, Y.; Zhao, K. Hypervalent iodine- mediated oxygenation of N,N-diaryl tertiary amines: Intramolecular functionalization of sp3 C-H bonds adjacent to nitrogen. J. Org. Chem. 2014, 79, 10581–10587. [Google Scholar] [CrossRef] [PubMed]
  26. Lagu, B.; Pio, B.; Lebedev, R.; Yang, M.; Pelton, P.D. RXR-LXR heterodimer modulators for the potential treatment of dyslipidemia. Bioorg. Med. Chem. Lett. 2007, 17, 3497–3503. [Google Scholar] [CrossRef] [PubMed]
  27. Ishida, T.; Kikuchi, S.; Tsubo, T.; Yamada, T. Silver-catalyzedincorporation of carbon dioxide into o-alkynylanilides derivatives. Org. Lett. 2013, 15, 848–851. [Google Scholar] [CrossRef] [PubMed]
  28. Tang, Z.; Chen, W.; Zhu, Z.; Liu, H. Synthesis of 2,3-diaryl-3,4-dihydro-2H-1,3-benzoxazines and their fungicidal activities. J. Heterocycl. Chem. 2011, 48, 255–260. [Google Scholar] [CrossRef]
  29. Tang, Z.; Zhu, Z.; Xia, Z.; Liu, H.; Chen, J.; Xiao, W.; Ou, X. Synthesis and fungicidal activity of novel 2,3-disubstituted-1,3-benzoxazines. Molecules 2012, 17, 8174–8185. [Google Scholar] [CrossRef] [PubMed]
Sample Availability: Samples of the compounds 5a–5r are available from the authors.
Molecules 22 01103 sch001 550
Scheme 1. Synthesis of 1-(carbamoylmethyl)-2-aryl-3,1-benzoxazines 5.
Scheme 1. Synthesis of 1-(carbamoylmethyl)-2-aryl-3,1-benzoxazines 5.
Molecules 22 01103 sch001
Table
Table 1. The results of the preparation of 3,1-benzoxazines 5a a.
Table 1. The results of the preparation of 3,1-benzoxazines 5a a.
No.RR1ConditionsProductYield/% b
1c2-CH3C6H43-NO2BF3·OEt2(10%), 65 °C, 6 hn(3):n(4) = 1:1.35a35
2c2-CH3C6H43-NO2BF3·OEt2(20%), 65 °C, 6 hn(3):n(4) = 1:1.35a45
32-CH3C6H43-NO2BF3·OEt2(20%), 65 °C, 6 hn(3):n(4) = 1:1.35a47
42-CH3C6H43-NO2BF3·OEt2(20%), 65 °C, 8 hn(3):n(4) = 1:1.35a50
52-CH3C6H43-NO2BF3·OEt2(20%), 65 °C, 10 hn(3):n(4) = 1:1.35a53
62-CH3C6H43-NO2BF3·OEt2(20%), 65 °C, 14 hn(3):n(4) = 1:1.35a44
72-CH3C6H43-NO2BF3·OEt2(20%), 65 °C, 10 hn(3):n(4) = 1:1.55a55
82-CH3C6H42-NO2BF3·OEt2(20%), 65 °C, 10 h5b45
92-CH3C6H44-NO2BF3·OEt2(20%), 65 °C, 10 h5c49
104-CH3C6H43-NO2BF3·OEt2(20%), 65 °C, 10 h5d56
114-CH3C6H42-NO2BF3·OEt2(20%), 65 °C, 10 h5e40
124-CH3C6H44-NO2BF3·OEt2(20%), 65 °C, 10 h5f48
134-CH3OC6H43-NO2BF3·OEt2(20%), 65 °C, 10 h5g85
144-CH3OC6H42-NO2BF3·OEt2(20%), 65 °C, 10 h5h66
154-CH3OC6H44-NO2BF3·OEt2(20%), 65 °C, 10 h5i80
163-CH3OC6H43-NO2BF3·OEt2(20%), 65 °C, 10 h5j74
173-CH3OC6H42-NO2BF3·OEt2(20%), 65 °C, 10 h5k41
183-CH3OC6H44-NO2BF3·OEt2(20%), 65 °C, 10 h5l60
19C6H53-NO2BF3·OEt2(20%), 65 °C, 10 h5m52
20C6H52-NO2BF3·OEt2(20%), 65 °C, 10 h5n44
21C6H54-NO2BF3·OEt2(20%), 65 °C, 10 h5o46
22C6H5CH23-NO2BF3·OEt2(20%), 65 °C, 10 h5p56
23C6H5CH22-NO2BF3·OEt2(20%), 65 °C, 10 h5q58
24C6H5CH24-NO2BF3·OEt2(20%), 65 °C, 10 h5r65
a Unless mentioned in the table, the reaction conditions were: the mole ratio of n (3):n (4) = 1:1.5; BF3·OEt2: 20 mol % based on compound 3; Solvent: THF; Molecular sieve 4Å added; Reaction time: 10 h; Temperature: 65 °C. b Isolated yield. c Without molecular sieve 4Å.
Table
Table 2. Fungicidal activities of compounds 5a–r.
Table 2. Fungicidal activities of compounds 5a–r.
Compd.S. sclerotiorum/%B. cinerea/%R. solani/%G. zeae/%P. capsici/%M. oryzae/% a
5a33.343.821.112.57.718.2
5b33.337.518.437.530.827.3
5c33.331.35.312.515.413.6
5d14.343.8 26.331.315.460.1
5e14.331.321.16.338.536.4
5f47.656.3 28.9 31.3 15.4 22.7
5g57.112.5 21.1 25.0 15.4 54.5
5h23.818.831.631.338.522.7
5i71.925.0 31.6 12.5 15.431.8
5j14.312.518.437.530.822.7
5k42.925.021.112.57.722.7
5l23.843.831.612.515.427.3
5m14.350.026.337.515.427.3
5n28.637.518.418.838.522.7
5o27.323.851.753.833.351.7
5p11.611.519.617.111.141.2
5q46.538.525.517.129.641.2
5r16.330.815.712.211.111.8
Chlorothalonil b84.992.985.267.678.653.8
a The value measured at concentration of 50 µg/mL. b Chlorothalonil used as reference compound.

Share and Cite

MDPI and ACS Style

Tang, Z.-L.; Wang, L.; Tan, J.-Z.; Wan, Y.-C.; Jiao, Y.-C. Synthesis and Fungicidal Activity of 1-(Carbamoylmethyl)-2-aryl-3,1-benzoxazines. Molecules 2017, 22, 1103. https://doi.org/10.3390/molecules22071103

AMA Style

Tang Z-L, Wang L, Tan J-Z, Wan Y-C, Jiao Y-C. Synthesis and Fungicidal Activity of 1-(Carbamoylmethyl)-2-aryl-3,1-benzoxazines. Molecules. 2017; 22(7):1103. https://doi.org/10.3390/molecules22071103

Chicago/Turabian Style

Tang, Zi-Long, Lian Wang, Jing-Zhao Tan, Yi-Chao Wan, and Yin-Chun Jiao. 2017. "Synthesis and Fungicidal Activity of 1-(Carbamoylmethyl)-2-aryl-3,1-benzoxazines" Molecules 22, no. 7: 1103. https://doi.org/10.3390/molecules22071103

APA Style

Tang, Z.-L., Wang, L., Tan, J.-Z., Wan, Y.-C., & Jiao, Y.-C. (2017). Synthesis and Fungicidal Activity of 1-(Carbamoylmethyl)-2-aryl-3,1-benzoxazines. Molecules, 22(7), 1103. https://doi.org/10.3390/molecules22071103

Article Metrics

Back to TopTop